✅ No sanctions, screening, insolvency or control red flags found in the public sources we cover. (Absence of a flag is not a guarantee — see methodology.)
PIERRE FABRE MEDICAMENT
SARL · Active since 1982
Overview
PIERRE FABRE MEDICAMENT is a limited liability company registered in lavaur, France, since 1982. With reported revenue of 1.2B EUR in 2024. Its TraceComp score of 87 (A) indicates solid fundamentals and low apparent risk. With 43 years of operations, the company has an established track record in its market.
Company Information
- Registration Number
- 326118502
- Legal Form
- SARL
- Registered
- 1982-12-27
- Address
- lavaur
Financial Profile
Latest filed accounts: FY 2024
Multi-year financials & ratios
5 years of filed accounts on file — full balance sheets, current ratio, debt-to-equity, net margin and the Altman-Z distress trend.
What’s in the full report
- Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
- Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
- Insolvency & legal events — collective proceedings and adverse filings (where on record)
- Charges & secured lending — registered charges and the creditors entitled (where filed)
- Sanctions & screening — company-level watchlist & adverse signals
- Sector benchmark & peers — how the company compares to its sector and nearest peers
- Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Officers & Management
4 officers/directors on file — names, roles, appointment & resignation dates.
| Name | Role | Status |
|---|---|---|
| MARIE-ANDRÉE GAMACHE | Président de SAS | Current |
What’s in the full report
- Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
- Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
- Insolvency & legal events — collective proceedings and adverse filings (where on record)
- Charges & secured lending — registered charges and the creditors entitled (where filed)
- Sanctions & screening — company-level watchlist & adverse signals
- Sector benchmark & peers — how the company compares to its sector and nearest peers
- Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Public Contracts Won
Awarded 135 public-sector contracts totalling EUR 780,993,164 (DECP).
Which public buyers, contract titles, values and award dates.
What’s in the full report
- Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
- Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
- Insolvency & legal events — collective proceedings and adverse filings (where on record)
- Charges & secured lending — registered charges and the creditors entitled (where filed)
- Sanctions & screening — company-level watchlist & adverse signals
- Sector benchmark & peers — how the company compares to its sector and nearest peers
- Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Patent Portfolio
Active patent holder. 263 patents · 164 active · 263 granted in the USPTO/EPO record.
See full patent portfolio — most-cited inventions & inventors →
Source: USPTO / EPO open patent data. Objective bibliographic counts.
Corporate Group & Ownership
Parent entities from the GLEIF global ownership graph (LEI Level 2).
| Relationship | Parent entity | Country |
|---|---|---|
| Direct parent | PIERRE FABRE SA | FR |
| Ultimate parent | PIERRE FABRE PARTICIPATIONS | FR |
Risk Signals
No adverse legal events have been recorded for this company.
- Profitable: positive net income in FY 2024
Similar Companies
Data Sources & Freshness
Data sourced from: official public registries.